UGA to collaborate with GeoVax on Zika vaccine
The University of Georgia has entered into a collaborative research agreement with GeoVax Labs Inc. to develop and test a vaccine to prevent the emerging and virulent Zika virus infection. The collaboration will combine the vaccine development expertise of UGA researchers led by GRA Eminent Scholar Ted Ross, who directs UGA’s Center for Vaccines and Immunology, with GeoVax’s novel vaccine platform technology.
